Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies

Immunotherapy, especially PD-1/PD-L1 checkpoint blockade immunotherapy, has led tumor therapy into a new era. However, the vast majority of patients do not benefit from immunotherapy. One possible reason for this lack of response is that the association between tumors, immune cells and metabolic rep...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Oncol
Main Authors: Ma, Guofeng, Li, Chun, Zhang, Zhilei, Liang, Ye, Liang, Zhijuan, Chen, Yuanbin, Wang, Liping, Li, Dan, Zeng, Manqin, Shan, Wenhong, Niu, Haitao
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2021
主題:
Oncology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314994/
https://ncbi.nlm.nih.gov/pubmed/34327138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.697894
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍